Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Equity Ratio (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Equity Ratio for 17 consecutive years, with 0.29 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 24.31% to 0.29 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.29 through Dec 2025, down 24.31% year-over-year, with the annual reading at 0.29 for FY2025, 24.31% down from the prior year.
  • Equity Ratio hit 0.29 in Q4 2025 for Integra Lifesciences Holdings, up from 0.28 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.46 in Q4 2022 to a low of 0.28 in Q2 2025.
  • Historically, Equity Ratio has averaged 0.4 across 5 years, with a median of 0.42 in 2023.
  • Biggest five-year swings in Equity Ratio: rose 7.62% in 2022 and later fell 24.79% in 2025.
  • Year by year, Equity Ratio stood at 0.45 in 2021, then increased by 4.14% to 0.46 in 2022, then dropped by 9.49% to 0.42 in 2023, then fell by 8.84% to 0.38 in 2024, then decreased by 24.31% to 0.29 in 2025.
  • Business Quant data shows Equity Ratio for IART at 0.29 in Q4 2025, 0.28 in Q3 2025, and 0.28 in Q2 2025.